Référence:
20220170
Date de publication: 13 avril 2023
Date de publication: 13 avril 2023
Promoteur – Intermédiaire Financier
DEK VACCINES LTDLieu
Description
The project consists in a grant facility of up to EUR 5m providing seed financing to support the construction, furnishing and validation of a fill and finish vaccine manufacturing facility in the suburbs of Accra, Ghana.
Objectifs
The facility will initially target vaccines that are a priority for the African continent and is expected to contribute to enhanced regional independence in health security.
Secteur(s)
- Industrie - Industrie manufacturière
Montant BEI envisagé (montant approximatif)
EUR 5 million
Coût total (montant approximatif)
EUR 47 million
Aspects environnementaux
The promoter is required to implement the project in accordance with the EIB's Environmental and Social Policy and Standards.
Passation des marchés
The promoter is required to implement the project in accordance with the EIB's Guide to Procurement.
Statut
Signé - 29/03/2023
Milestone
À l'examen
Approuvé
Signé
27 mars 2023
29 mars 2023